Skip Header

14 results for uniprot:P01242 in Computationally mapped citations

Page 1 of 1

to top of page·  

Results Customize

Late life metabolic syndrome, early growth, and common polymorphism in the growth hormone and placental lactogen gene cluster.

Day I.N., Chen X.H., Gaunt T.R., King T.H., Voropanov A., Ye S., Rodriguez S., Syddall H.E., Sayer A.A., Dennison E.M. et al.

J. Clin. Endocrinol. Metab. 89:5569-5576(2004) GAD 123925 GeneRIF 2689 · Mapped (12)
Associated with METABOLIC: metabolic syndrome; GAD 123925 Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator) GeneRIF 2689

Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells.

Graichen R., Liu D., Sun Y., Lee K.O., Lobie P.E.

J. Biol. Chem. 277:26662-26672(2002) GeneRIF 2689 · Mapped (11)
report that autocrine hGH production by mammary carcinoma cells specifically results in the transcriptional repression of the p53-regulated placental transforming growth factor-beta gene (Placental growth factor-beta; TGF-beta) GeneRIF 2689

Intracellular signaling by growth hormone variant (GH-V).

Silva C.M., Kloth M.T., Lyons C.E., Dunn C.R., Kirk S.E.

Growth Horm. IGF Res. 12:374-380(2002) GeneRIF 2689 · Mapped (3)
GH-V plays a major role in affecting target cells expressing the GH receptor thus potentially exerting significant GH-like effects on maternal physiology during pregnancy. GeneRIF 2689

The functional binding epitope of a high affinity variant of human growth hormone mapped by shotgun alanine-scanning mutagenesis: insights into the mechanisms responsible for improved affinity.

Pal G., Kossiakoff A.A., Sidhu S.S.

J. Mol. Biol. 332:195-204(2003) GeneRIF 2689 · Mapped (3)
Data show that improved binding affinity of human growth hormone (hGH(v)) results from numerous small contributions distributed broadly over the interface. GeneRIF 2689

The high- and low-affinity receptor binding sites of growth hormone are allosterically coupled.

Walsh S.T., Sylvester J.E., Kossiakoff A.A.

Proc. Natl. Acad. Sci. U.S.A. 101:17078-17083(2004) GeneRIF 2689 · Mapped (7)
Using a mutagenesis-scanning analysis of 81 single and 32 pairwise double mutations it is shown that the GHv hormone's two spatially distal receptor binding sites (Site1 and Site2) are allosterically coupled GeneRIF 2689

Stimulation of human trophoblast invasion by placental growth hormone.

Lacroix M.C., Guibourdenche J., Fournier T., Laurendeau I., Igout A., Goffin V., Pantel J., Tsatsaris V., Evain-Brion D.

Endocrinology 146:2434-2444(2005) GeneRIF 2689 · Mapped (3)
results offer the first evidence for a placental role of human placental growth hormone(hPGH) and suggest an autocrine/paracrine role of hPGH in the regulation of trophoblast invasion GeneRIF 2689

Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.

Mittal P., Espinoza J., Hassan S., Kusanovic J.P., Edwin S.S., Nien J.K., Gotsch F., Than N.G., Erez O., Mazaki-Tovi S. et al.

J. Matern. Fetal. Neonatal. Med. 20:651-659(2007) GeneRIF 2689 · Mapped (3)
PGH may play a role in the mechanisms of disease in preeclampsia and fetal growth restriction. GeneRIF 2689

Regulation of placental growth hormone secretion in a human trophoblast model--the effects of hormones and adipokines.

Zeck W., Widberg C., Maylin E., Desoye G., Lang U., McIntyre D., Prins J., Russell A.

Pediatr. Res. 63:353-357(2008) GeneRIF 2689 · Mapped (8)
Placental growth hormone (PGH) secretion by BeWo cells is regulated by hormonal factors and adipokines. Elevated insulin and leptin levels might down-regulate PGH secretion. GeneRIF 2689

Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome.

Christiansen M.

Prenat. Diagn. 29:1249-1255(2009) GeneRIF 2689 · Mapped (7)
early first trimester maternal serum marker for Down syndrome GeneRIF 2689

hGH-V gene expression and promoter activity under glucose and 5-azacytidine (5azaC) effects.

de Jesus Romero-Prado M.M., Barrera-Saldana H.A., Castrillo-Diez J.L.

Gene 452:7-15(2010) GeneRIF 2689 · Mapped (3)
The hGH-V promoter activity and the endogenous mRNA expression in human placental choriocarcinoma cell line JAR in the presence of glucose and demethylating genome conditions were compared. GeneRIF 2689

A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence.

McElholm A.R., McKnight A.J., Patterson C.C., Johnston B.T., Hardie L.J., Murray L.J.

Gastroenterology 139:204-12.e3(2010) GeneRIF 2689 · Mapped (24)
Observational study of gene-disease association. (HuGE Navigator) GeneRIF 2689

Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic pregnancy.

Higgins M.F., Russell N.E., Crossey P.A., Nyhan K.C., Brazil D.P., McAuliffe F.M.

PLoS ONE 7:e29164-e29164(2012) GeneRIF 2689 · Mapped (27)
These results suggest that the normal PGH-IGF-I-IGFBP3 axis in pregnancy is abnormal in Type 1 Diabetic pregnancies. GeneRIF 2689

Differential placental expression profile of human Growth Hormone/Chorionic Somatomammotropin genes in pregnancies with pre-eclampsia and gestational diabetes mellitus.

Mannik J., Vaas P., Rull K., Teesalu P., Laan M.

Mol. Cell. Endocrinol. 355:180-187(2012) GeneRIF 2689 · Mapped (5)
results are consistent with a pleiotropic effect of placental hGH/CSH genes at the maternal-fetal interface relating to the regulation of fetal growth and the risk of affected maternal metabolism. GeneRIF 2689

Maternal serum placental growth hormone at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates.

Sifakis S., Akolekar R., Kappou D., Mantas N., Nicolaides K.H.

J. Matern. Fetal. Neonatal. Med. 25:1796-1799(2012) GeneRIF 2689 · Mapped (3)
Maternal serum PGH at 11-13 weeks' gestation is unlikely to be a useful biochemical marker for early prediction of small for gestational age neonates. GeneRIF 2689

to top of page·

Page 1 of 1